Evinacumab

Records for this ingredient, by country (identity only).

ATC C10AX17 · 6 markets · 6 records

Evinacumab 6 markets · 6 records Forms
Filters

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 345 mg/2.3 mLinjectionEvkeeza 345mg/2.3ml concentrate for solution for infusion vials also in JP

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 150 mg per mL / per unit basis not statedliquidEVKEEZA

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 345 mg/2.3 mLinjectionエヴキーザ点滴静注液345mg also in GB

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 150 mg/1 mLinjectionEVKEEZA 150 mg/ml, solution à diluer pour perfusion also in ES

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.